Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

• Үндсэн зохиолчид: Matthias Eder (Зохиогч), Oliver Neels (Зохиогч), Miriam Müller (Зохиогч), Ulrike Bauder-Wüst (Зохиогч), Yvonne Remde (Зохиогч), Martin Schäfer (Зохиогч), Ute Hennrich (Зохиогч), Michael Eisenhut (Зохиогч), Ali Afshar-Oromieh (Зохиогч), Uwe Haberkorn (Зохиогч), Klaus Kopka (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2014-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane antigen (PSMA) has gained highest clinical impact during the last years. 68Ga-labelled Glu-urea-Lys(Ahx)-HBED-CC ([68Ga]Ga-PSMA-HBED-CC) represents a successful novel PSMA inhibitor radiotracer which has recent...